Skip to main content
. 2014 Oct 7;21(1):94. doi: 10.1186/s12929-014-0094-y

Figure 3.

Figure 3

Plasma ICAM in all study groups. a. Control b. Diabetics without complications c. Diabetics with vasculopathy.